Initial Testing (Stage 1) of Vorinostat (SAHA) by the Pediatric Preclinical Testing Program

Vorinostat, a histone deacetylase inhibitor, was evaluated against the in vitro and in vivo childhood solid tumor and leukemia models in the Pediatric Preclinical Testing Program (PPTP). In vitro testing was performed by the DIMSCAN cytotoxicity assay. In vivo, vorinostat was administered intraperit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Keshelava, Nino, Houghton, Peter J., Morton, Christopher L., Lock, Richard B., Carol, Hernan, Keir, Stephen T., Maris, John M., Reynolds, C Patrick, Gorlick, Richard, Kolb, E. Anders, Wu, Jianrong, Smith, Malcolm A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752378/
https://ncbi.nlm.nih.gov/pubmed/19418547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21988
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky